Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.935 USD | -2.49% | +14.31% | +71.47% |
07/05 | Transcript : Heron Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
07/05 | Heron Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+71.47% | 453M | |
+24.97% | 46.71B | |
+48.83% | 41.8B | |
-1.19% | 41.52B | |
-3.42% | 29.55B | |
+10.45% | 25.78B | |
-21.17% | 19.26B | |
+1.22% | 12.14B | |
-3.18% | 12.08B | |
+27.34% | 11.98B |
- Stock Market
- Equities
- HRTX Stock
- News Heron Therapeutics, Inc.
- Needham Adjusts Price Target on Heron Therapeutics to $5 From $6, Maintains Buy Rating